Browsing by Author "Pavlovic, Andrija (57204964008)"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Clinical and Hemodynamic Outcomes with Enalapril Orodispersible Minitablets in Young Children with Heart Failure Due to Congenital Heart Disease(2024) ;Bijelic, Maja (56807060700) ;Djukic, Milan (23988377500) ;Vukomanovic, Vladislav (55881072000) ;Parezanovic, Vojislav (14325763000) ;Lazic, Milica (59569283700) ;Pavlovic, Andrija (57204964008) ;Popovic, Sasa (57200324005) ;Parezanovic, Miro (57210203543) ;Stefanovic, Igor (23470878000) ;Djordjevic, Stefan (57192951203) ;Ninic, Sanja (51864038300) ;Prijic, Sergej (20734985500) ;Bozic Cvijan, Bojana (56689582200) ;Jovanovic, Ida (23989306000)Bajcetic, Milica (15727461400)Background: The angiotensin-converting enzyme inhibitor (ACEI) enalapril is often administered to infants and young children with heart failure (HF) in various dosing regimens and formulations not adapted for their age. Methods: This prospective, two-center, open-label 8-week study evaluated an age-appropriate formulation of orodispersible minitablets (ODMTs) of enalapril (0.25 mg and 1 mg) in children aged 0 to 6 years with HF due to congenital heart disease. An age/weight-based dosing schedule was followed. Measures of echocardiographic parameters, blood pressure, heart rate, modified Ross score, and biochemistry were obtained over the 8-week period. The following two groups were assessed: ACEI-naïve and ACEI-pretreated patients. Results: In total, 53 children (age range of 0.05 to 4.8 years) were enrolled and 29 were ACEI-naïve. The average enalapril dose was 0.098 mg/kg (0.06–0.17 mg/kg) in the naïve group and 0.15 mg/kg (0.07–0.3 mg/kg) in pretreated patients. After 8 weeks, the modified Ross score and left ventricular diastolic dimension (LVD) z-score showed a significant decrease in both groups (p < 0.005). During 8 weeks follow-up, there were no difference in the z-scores for the systolic blood pressure (p = 0.071) or heart rate (p = 0.146). Conclusions: Pediatric patients treated with ODMTs of enalapril for 8 weeks had favorable improvements in LVD and HF symptoms. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Correlation of Near-Infrared Spectroscopy (NIRS) with Invasive Arterial Pressure Monitoring during Aortic Coarctation Surgery in Pediatric Patients(2024) ;Pjevalica Dragic, Jelena (59347581200) ;Zecevic, Tatjana (57189059739) ;Divac, Ivan (57205046248) ;Pavlovic, Andrija (57204964008) ;Bisenic, Dejan (57246618300) ;Stanisic, Luka (59347038800) ;Kalanj, Jasna (8405619200) ;Stefanovic, Igor (23470878000) ;Nikolic, Dejan (26023650800) ;Petrov, Ivana (57223134429)Milovanovic, Vladimir (36935585800)Aortic coarctation surgery in pediatric patients requires the placement of two arterial cannulas to monitor pressure gradients and surgical correction adequacy. Near-infrared spectroscopy (NIRS) monitoring provides insight into regional blood flow. This study aimed to investigate the correlation between NIRS values and invasive arterial pressures, exploring NIRS monitoring as a potential substitute for arterial cannulation. In a cohort of 21 consecutive pediatric patients undergoing aortic coarctation surgery, recordings of NIRS and invasive arterial pressure values were evaluated at various time intervals. Pearson correlation evaluated the relationship between NIRS values and invasively measured arterial pressures. Moderate to strong correlations were observed between the mean arterial pressure (MAP) of the upper and lower arteries and cerebral (rSO2-C) and somatic (rSO2-S) NIRS values 5 min after cross-clamp placement (r = 0.621, p = 0.003; r = 0.757, p < 0.001). Strong correlations were found 15 min after cross-clamp placement (r = 0.828, p = 0.002; r = 0.783, p = 0.004). Before transfer to the ICU, a strong correlation existed between the upper artery MAP and rSO2-C (r = 0.730, p < 0.001), but there was no correlation between the lower artery MAP and rSO2-S. These findings are promising, but further studies are required to validate it as a reliable substitute for invasive pressure monitoring in this patient population. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Correlation of Near-Infrared Spectroscopy (NIRS) with Invasive Arterial Pressure Monitoring during Aortic Coarctation Surgery in Pediatric Patients(2024) ;Pjevalica Dragic, Jelena (59347581200) ;Zecevic, Tatjana (57189059739) ;Divac, Ivan (57205046248) ;Pavlovic, Andrija (57204964008) ;Bisenic, Dejan (57246618300) ;Stanisic, Luka (59347038800) ;Kalanj, Jasna (8405619200) ;Stefanovic, Igor (23470878000) ;Nikolic, Dejan (26023650800) ;Petrov, Ivana (57223134429)Milovanovic, Vladimir (36935585800)Aortic coarctation surgery in pediatric patients requires the placement of two arterial cannulas to monitor pressure gradients and surgical correction adequacy. Near-infrared spectroscopy (NIRS) monitoring provides insight into regional blood flow. This study aimed to investigate the correlation between NIRS values and invasive arterial pressures, exploring NIRS monitoring as a potential substitute for arterial cannulation. In a cohort of 21 consecutive pediatric patients undergoing aortic coarctation surgery, recordings of NIRS and invasive arterial pressure values were evaluated at various time intervals. Pearson correlation evaluated the relationship between NIRS values and invasively measured arterial pressures. Moderate to strong correlations were observed between the mean arterial pressure (MAP) of the upper and lower arteries and cerebral (rSO2-C) and somatic (rSO2-S) NIRS values 5 min after cross-clamp placement (r = 0.621, p = 0.003; r = 0.757, p < 0.001). Strong correlations were found 15 min after cross-clamp placement (r = 0.828, p = 0.002; r = 0.783, p = 0.004). Before transfer to the ICU, a strong correlation existed between the upper artery MAP and rSO2-C (r = 0.730, p < 0.001), but there was no correlation between the lower artery MAP and rSO2-S. These findings are promising, but further studies are required to validate it as a reliable substitute for invasive pressure monitoring in this patient population. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Highlighting early detection of thyroid pathology and gestational diabetes effects on oxidative stress that provokes preterm delivery in thyroidology: Does that ring a bell?(2023) ;Dugalic, Stefan (26648755300) ;Todorovic, Jovana (7003376825) ;Sengul, Demet (22938589200) ;Sengul, Ilker (26323870100) ;Veiga, Eduardo Carvalho de Arruda (44462234600) ;Plesinac, Jovana (58046514300) ;Petronijevic, Milica (58134579600) ;Macura, Maja (57219966636) ;Kepeci, Sonja Perkovic (57210802062) ;Milinčić, Miloš (58155347800) ;Pavlovic, Andrija (57204964008)Gojnic, Miroslava (9434266300)Objectives: Ad fontes, the status of the thyroid gland, and metabolic disturbance lead to the alteration of oxygenation. In pregnancy, it is particularly crucial to possess all predictive parameters. Methods: This cross-sectional study was conducted at the Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia, between 2017 and 2021 which study included a total of 99 women who had been admitted for preterm delivery and had undergone thyroid analysis, detected Hashimoto thyroiditis, and Oral Glucose Tolerance Test (OGTT) 40 days after delivery and had pathological Homeostatic Model Assessment for Insulin Response (HOMA IR) indices. In the group of urgent patients with preterm delivery, we looked after not only routine Doppler of the umbilical artery, but we measured specific ratios such as the Cerebroplacental ratio (CP). Results: The mean maternal age was 32.23 ± 5.96 years and the mean gestational age was detected as 35.40 ± 2.39 weeks. The delivery was completed vaginally in 77 women (78%) and surgically in 22 (22%). The Mean APGAR score was 8.44 ± 1.18, the mean birth weight was 2666.87 ± 622.17g and the cases undergoing cesarean section had significantly higher values of pulsatility index (1.85 ± 0.27 vs. 1.34 ± 0.31) and CP (1.22 ± 0.26 vs. 0.47 ± 0.17). Conclusions: The introduction of Doppler sonography for blood flow assessment helps to form a complete clinical description of the patient, particularly in conditions where oxidative stress became provocative by the thyroid gland antibodies and gestational diabetes in Thyroidology. © 2023 HCFMUSP - Some of the metrics are blocked by yourconsent settings
Publication Immediate results of primary balloon dilation for congenital aortic valve stenosis predict the mid-term outcome(2023) ;Pavlovic, Andrija (57204964008) ;Parezanovic, Vojislav (14325763000) ;Stefanovic, Igor (23470878000) ;Dähnert, Ingo (7003952605) ;Tzifa, Aphrodite (6506454960) ;Djordjevic, Stefan A. (57192951203) ;Ilic, Slobodan (57212487618) ;Milovanovic, Vladimir (36935585800) ;Bijelic, Maja (56807060700) ;Bisenic, Dejan (57246618300) ;Kalanj, Jasna (8405619200)Djukic, Milan (23988377500)Background: Balloon valvuloplasty is the primary treatment for congenital aortic valve stenosis in our centre. We sought to determine independent predictors of reintervention (surgical repair or repeated balloon dilation) after primary valvuloplasty. Methods: We retrospectively studied patients with congenital aortic valve stenosis who underwent balloon valvuloplasty during 2004-2018. The following risk factors were analysed: aortic valve insufficiency after balloon valvuloplasty >+1/4, post-procedural gradient across the aortic valve ≥35 mmHg, pre-interventional gradient across the valve, annulus size, use of rapid pacing, and balloon/annulus ratio. Primary outcome was aortic valve reintervention. Results: In total, 99 patients (median age 4 years, range 1 day to 26 years) underwent balloon valvuloplasty for congenital aortic valve stenosis. After a mean follow-up of 4.0 years, 30% had reintervention. Adjusted risks for reintervention were significantly increased in patients with post-procedural aortic insufficiency grade >+1/4 and/or residual gradient ≥35 mmHg (HR 2.55, 95% CI 1.13-5.75, p = 0.024). Pre-interventional gradient, annulus size, rapid pacing, and balloon/annulus ratio were not associated with outcome. Conclusion: Post-procedural aortic valve insufficiency grade >+1/4 and/or residual gradient ≥35 mmHg in patients undergoing balloon valvuloplasty for congenital aortic valve stenosis confers an increased risk for reintervention in mid-term follow-up. © The Author(s), 2023. Published by Cambridge University Press. - Some of the metrics are blocked by yourconsent settings
Publication Prognostic impact of non-culprit chronic total occlusion over time in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention(2021) ;Milasinovic, Dejan (24823024500) ;Mladenovic, Djordje (58483820500) ;Zaharijev, Stefan (58483845200) ;Mehmedbegovic, Zlatko (55778381000) ;Marinkovic, Jelena (7004611210) ;Jelic, Dario (57201640680) ;Zobenica, Vladimir (58118595100) ;Radomirovic, Marija (58483860800) ;Dedovic, Vladimir (55959310400) ;Pavlovic, Andrija (57204964008) ;Dobric, Milan (23484928600) ;Stojkovic, Sinisa (6603759580) ;Asanin, Milika (8603366900) ;Vukcevic, Vladan (15741934700)Stankovic, Goran (59150945500)Aims: Previous studies indicated that a chronic total occlusion (CTO) in a non-infarct-related artery is linked to higher mortality mainly in the acute setting in patients with ST-elevation myocardial infarction (STEMI). Our aim was to assess the temporal distribution of mortality risk associated with non-culprit CTO over years after STEMI. Methods and results: The study included 8679 STEMI patients treated with primary percutaneous coronary intervention (PCI). Kaplan-Meier cumulative mortality curves for non-culprit CTO vs. no CTO were compared with log-rank test, with landmarks set at 30 days and 1 year. Adjusted Cox regression models were constructed to assess the impact of non-culprit CTO on mortality over different time intervals. Tests for interaction were pre-specified between non-culprit CTO and acute heart failure and left ventricular ejection fraction. The primary outcome variable was all-cause mortality, and the median follow-up was 5 years. Non-culprit CTO was present in 11.6% of patients (n = 1010). Presence of a CTO was associated with increased early [30-day adjusted hazard ratio (HR) 1.91, 95% confidence interval (CI) 1.54-2.36; P < 0.001] and late mortality (5-year adjusted HR 1.66, 95% CI 1.42-1.95; P < 0.001). Landmark analyses revealed an annual two-fold increase in mortality in patients with vs. without a CTO after the first year of follow-up. The observed pattern of mortality increase over time was independent of acute or chronic LV impairment. Conclusions: Non-culprit CTO is independently associated with mortality over 5 years after primary PCI for STEMI, with a constant annual two-fold increase in the risk of death beyond the first year of follow-up. © 2021.
